StoneX Group’s Envoy Medical COCH Stock Holding History

StoneX Group’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$256K	–	413
2023 Q2	$256K	Buy	+25,000	New	+$253K	0.14%	226

Other funds holding COCH

Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

StoneX Group's COCH Position: Q3 2023 in Review

StoneX Group sold out of Envoy Medical (COCH) in Q3 2023, closing a stake of 25,000 shares — an estimated $256K sold.

StoneX Group first reported a position in COCH in Q2 2023 and held it in 1 quarter. The position peaked at $256K in Q2 2023. 16 funds tracked by Wall St. Rank hold COCH as of Q3 2023.

StoneX Group reported no remaining Envoy Medical position as of Q3 2023 after selling out during the quarter.
StoneX Group sold 25,000 Envoy Medical shares in Q3 2023, an estimated $256K.
StoneX Group first reported a position in Envoy Medical in Q2 2023 and held it in 1 quarter.
StoneX Group's Envoy Medical position peaked at $256K in Q2 2023.
16 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2023.

Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.